CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more ...
Introduction Cancer is a leading cause of death globally. Breast cancer accounts for 30% of all cancer cases and 15% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results